Neoplastic hypercalcemia: Physiologic response to intravenous etidronate disodium
Open Access
- 1 February 1987
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 82 (2), 42-50
- https://doi.org/10.1016/0002-9343(87)90486-4
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- Vitamin D-endocrine system.JCI Insight, 1985
- Immobilisation hypercalcaemia in adults and treatment with clodronate.BMJ, 1984
- Acute Intravenous Infusion of Disodium Dihydrogen ( 1 -Hydroxyethylidene)diphosphonate: Mechanism of ToxicityJournal of Pharmaceutical Sciences, 1984
- Disodium etidronate in hypercalcaemia due to immobilisation.BMJ, 1984
- Treatment of Paget's Disease of Bone with Ethane-1, Hydroxy-1,1 Diphosphonate (EHDP) at a Low Dosage (5 mg/kg/day)Published by Wolters Kluwer Health ,1983
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.JCI Insight, 1980
- EFFECTS OF DISODIUM DICHLOROMETHYLENE DIPHOSPHONATE ON PAGET'S DISEASE OF BONEThe Lancet, 1979
- Response of 1α,25-Dihydroxyvitamin D3to Hypocalcemia in Human SubjectsNew England Journal of Medicine, 1978